Antibiofilm activity of lactoferrin-derived synthetic peptides against Pseudomonas aeruginosa PAO1
- PMID: 32871093
- DOI: 10.1139/bcb-2020-0253
Antibiofilm activity of lactoferrin-derived synthetic peptides against Pseudomonas aeruginosa PAO1
Abstract
Many pathogenic bacteria can protect themselves from the effects of antibiotics and the host immune response system by forming biofilms. Biofilms are polymer-entrapped bacterial cells, which adhere to each other and are often attached to a surface. Eradication of bacterial biofilms typically requires much higher concentrations of antibiotics than are normally needed to kill cultured planktonic cells, raising serious clinical concerns. In an attempt to prevent the formation of biofilms or to break up existing biofilms of pathogenic bacteria, herein we have used the standard crystal violet assay as well as the Calgary biofilm device to test several lactoferrin- and lactoferricin-derived antimicrobial peptides for their antibiofilm activity against Pseudomonas aeruginosa PAO1. Our results revealed that the short bovine lactoferricin-derived RRWQWR-NH2 (20-25) hexapeptide has no activity against P. aeruginosa PAO1. Moreover, the longer human lactoferricin-derived peptide GRRRRSVQWCA (1-11) and the bovine lactoferrampin (268-284) peptide were also almost devoid of activity. However, several different "mix-and-match" dimeric versions of the two lactoferricin-derived peptides proved quite effective in preventing the formation of biofilms at low concentrations, and in some cases, could even eradicate an existing biofilm. Moreover, the full-length bovine lactoferricinB (17-41) peptide also displayed considerable antimicrobial activity. Some of the longer lactoferricin-derived dimeric peptides acted through a bactericidal mechanism, whereas others seemed to interfere in cell-signalling processes. Taken together, our results indicate that synthetic dimeric peptides comprising short naturally occurring human and bovine lactoferricin constructs could be further developed as antibiofilm agents.
Keywords: Pseudomonas aeruginosa; antibiofilm peptides; biofilm; conception de peptides; crystal violet assay; lactoferricin; lactoferricine; lactoferrin; lactoferrine; peptide design; peptides « antibiofilm »; test au cristal violet.
Similar articles
-
Antimicrobial activity of synthetic cationic peptides and lipopeptides derived from human lactoferricin against Pseudomonas aeruginosa planktonic cultures and biofilms.BMC Microbiol. 2015 Jul 7;15:137. doi: 10.1186/s12866-015-0473-x. BMC Microbiol. 2015. PMID: 26149536 Free PMC article.
-
Lactoferrin-derived peptides and Lactoferricin chimera inhibit virulence factor production and biofilm formation in Pseudomonas aeruginosa.J Appl Microbiol. 2010 Oct;109(4):1311-8. doi: 10.1111/j.1365-2672.2010.04751.x. Epub 2010 Aug 19. J Appl Microbiol. 2010. PMID: 20477900
-
Critical Assessment of Methods to Quantify Biofilm Growth and Evaluate Antibiofilm Activity of Host Defence Peptides.Biomolecules. 2018 May 21;8(2):29. doi: 10.3390/biom8020029. Biomolecules. 2018. PMID: 29883434 Free PMC article.
-
Towards a structure-function analysis of bovine lactoferricin and related tryptophan- and arginine-containing peptides.Biochem Cell Biol. 2002;80(1):49-63. doi: 10.1139/o01-213. Biochem Cell Biol. 2002. PMID: 11908643 Review.
-
Anti herpes simplex virus activity of lactoferrin/lactoferricin -- an example of antiviral activity of antimicrobial protein/peptide.Cell Mol Life Sci. 2005 Dec;62(24):3002-13. doi: 10.1007/s00018-005-5228-7. Cell Mol Life Sci. 2005. PMID: 16261265 Free PMC article. Review.
Cited by
-
Topical Antibiofilm Agents With Potential Utility in the Treatment of Chronic Rhinosinusitis: A Narrative Review.Front Pharmacol. 2022 Jun 13;13:840323. doi: 10.3389/fphar.2022.840323. eCollection 2022. Front Pharmacol. 2022. PMID: 35770097 Free PMC article. Review.
-
In Vitro Antimycobacterial Activity of Human Lactoferrin-Derived Peptide, D-hLF 1-11, against Susceptible and Drug-Resistant Mycobacterium tuberculosis and Its Synergistic Effect with Rifampicin.Antibiotics (Basel). 2022 Dec 9;11(12):1785. doi: 10.3390/antibiotics11121785. Antibiotics (Basel). 2022. PMID: 36551443 Free PMC article.
-
Design and Evaluation of Short Bovine Lactoferrin-Derived Antimicrobial Peptides against Multidrug-Resistant Enterococcus faecium.Antibiotics (Basel). 2022 Aug 10;11(8):1085. doi: 10.3390/antibiotics11081085. Antibiotics (Basel). 2022. PMID: 36009954 Free PMC article.
-
Priming With Toll-Like Receptor 3 Agonist Poly(I:C) Enhances Content of Innate Immune Defense Proteins but Not MicroRNAs in Human Mesenchymal Stem Cell-Derived Extracellular Vesicles.Front Cell Dev Biol. 2021 May 24;9:676356. doi: 10.3389/fcell.2021.676356. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34109180 Free PMC article.
-
Host-microbe interactions in chronic rhinosinusitis biofilms and models for investigation.Biofilm. 2023 Sep 29;6:100160. doi: 10.1016/j.bioflm.2023.100160. eCollection 2023 Dec 15. Biofilm. 2023. PMID: 37928619 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical